Reuters logo
BRIEF-Mayne Pharma updates on FDA approval and first generic launch of Acticlate tablets
June 14, 2017 / 11:30 PM / 5 months ago

BRIEF-Mayne Pharma updates on FDA approval and first generic launch of Acticlate tablets

June 15 (Reuters) - Mayne Pharma Group Ltd:

* FDA approval and first generic launch of acticlate tablets

* U.S. FDA granted approval of ANDA for doxycycline hyclate immediate release (IR) tablets (75 MG AND 150 MG) in United States

* Mayne Pharma has immediately commenced commercial launch to customers in U.S. Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below